Alembic Pharmaceuticals Yönetim
Yönetim kriter kontrolleri 1/4
Alembic Pharmaceuticals CEO'su Chirayu Amin, Apr2016 tarihinde atandı, in görev süresi 8.58 yıldır. in toplam yıllık tazminatı ₹ 193.80M olup, şirket hissesi ve opsiyonları dahil olmak üzere 48.4% maaş ve 51.6% ikramiyelerden oluşmaktadır. şirketin hisselerinin 2.13% ine doğrudan sahiptir ve bu hisseler ₹ 4.35B değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 1.4 yıl ve 9.8 yıldır.
Anahtar bilgiler
Chirayu Amin
İcra Kurulu Başkanı
₹193.8m
Toplam tazminat
| CEO maaş yüzdesi | 48.4% |
| CEO görev süresi | 8.6yrs |
| CEO sahipliği | 2.1% |
| Yönetim ortalama görev süresi | 1.4yrs |
| Yönetim Kurulu ortalama görev süresi | 9.8yrs |
Son yönetim güncellemeleri
Recent updates
Earnings Miss: Alembic Pharmaceuticals Limited Missed EPS By 5.6% And Analysts Are Revising Their Forecasts
Nov 10
Alembic Pharmaceuticals Limited's (NSE:APLLTD) Intrinsic Value Is Potentially 17% Below Its Share Price
Sep 25Is Alembic Pharmaceuticals (NSE:APLLTD) Using Too Much Debt?
Sep 03Alembic Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 13Market Participants Recognise Alembic Pharmaceuticals Limited's (NSE:APLLTD) Earnings Pushing Shares 25% Higher
Jul 20Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Rather Sparingly
Jun 03Does This Valuation Of Alembic Pharmaceuticals Limited (NSE:APLLTD) Imply Investors Are Overpaying?
May 11Results: Alembic Pharmaceuticals Limited Exceeded Expectations And The Consensus Has Updated Its Estimates
Feb 08Subdued Growth No Barrier To Alembic Pharmaceuticals Limited (NSE:APLLTD) With Shares Advancing 25%
Jan 21Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?
Jan 05Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Can Manage Its Debt Responsibly
Sep 27Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly
Jun 09A Look At The Fair Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)
Apr 13Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?
Feb 22Alembic Pharmaceuticals Limited (NSE:APLLTD) Shares Could Be 21% Below Their Intrinsic Value Estimate
Jan 04We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Alembic Pharmaceuticals Limited's (NSE:APLLTD) CEO For Now
Nov 05Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Has A Meaningful Debt Burden
Aug 10Estimating The Intrinsic Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)
Jul 20CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹6b |
| Jun 30 2024 | n/a | n/a | ₹6b |
| Mar 31 2024 | ₹194m | ₹94m | ₹6b |
| Dec 31 2023 | n/a | n/a | ₹6b |
| Sep 30 2023 | n/a | n/a | ₹5b |
| Jun 30 2023 | n/a | n/a | ₹5b |
| Mar 31 2023 | ₹88m | ₹88m | ₹3b |
| Dec 31 2022 | n/a | n/a | ₹2b |
| Sep 30 2022 | n/a | n/a | ₹3b |
| Jun 30 2022 | n/a | n/a | ₹3b |
| Mar 31 2022 | ₹280m | ₹80m | ₹5b |
| Dec 31 2021 | n/a | n/a | ₹8b |
| Sep 30 2021 | n/a | n/a | ₹9b |
| Jun 30 2021 | n/a | n/a | ₹10b |
| Mar 31 2021 | ₹315m | ₹65m | ₹11b |
| Dec 31 2020 | n/a | n/a | ₹12b |
| Sep 30 2020 | n/a | n/a | ₹11b |
| Jun 30 2020 | n/a | n/a | ₹10b |
| Mar 31 2020 | ₹265m | ₹65m | ₹8b |
| Dec 31 2019 | n/a | n/a | ₹7b |
| Sep 30 2019 | n/a | n/a | ₹7b |
| Jun 30 2019 | n/a | n/a | ₹6b |
| Mar 31 2019 | ₹255m | ₹55m | ₹6b |
| Dec 31 2018 | n/a | n/a | ₹6b |
| Sep 30 2018 | n/a | n/a | ₹5b |
| Jun 30 2018 | n/a | n/a | ₹4b |
| Mar 31 2018 | ₹220m | ₹55m | ₹4b |
Tazminat ve Piyasa: Chirayu 'nin toplam tazminatı ($USD 2.29M ), Indian pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 589.97K ).
Tazminat ve Kazançlar: Chirayu 'in maaşı son bir yılda %20'den fazla arttı.
CEO
Chirayu Amin (78 yo)
8.6yrs
Görev süresi
₹193,800,000
Tazminat
Mr. Chirayu Ramanbhai Amin, M.B.A. (U.S.A.), has been Chief Executive Officer of Alembic Pharmaceuticals Limited since April 27, 2016. Mr. Amin served as Managing Director of Alembic Pharmaceuticals Limite...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Executive Chairman & CEO | 8.6yrs | ₹193.80m | 2.13% ₹ 4.4b | |
| Managing Director | less than a year | ₹190.90m | 0.59% ₹ 1.2b | |
| MD & Executive Director | 9.6yrs | ₹122.20m | 0.51% ₹ 1.0b | |
| Director of Finance | no data | ₹56.90m | Veri yok | |
| Head of Technical Operations | less than a year | Veri yok | Veri yok | |
| Chief Scientific Officer | no data | ₹8.41m | Veri yok | |
| Company Secretary & Compliance Officer | 1.6yrs | Veri yok | Veri yok | |
| Chief Business Development Officer | no data | ₹8.30m | 0.51% ₹ 1.0b | |
| Senior Vice President | no data | ₹8.12m | Veri yok | |
| Senior Vice President of Finance | no data | ₹9.20m | Veri yok | |
| Senior Vice President of Supply Chain | no data | Veri yok | Veri yok | |
| Head of International Business & Strategy | 1.3yrs | Veri yok | Veri yok |
1.4yrs
Ortalama Görev Süresi
63yo
Ortalama Yaş
Deneyimli Yönetim: APLLTD 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.4 yıl), bu da yeni bir ekibin varlığını gösteriyor.
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Executive Chairman & CEO | 14.4yrs | ₹193.80m | 2.13% ₹ 4.4b | |
| MD & Executive Director | 11.5yrs | ₹122.20m | 0.51% ₹ 1.0b | |
| Director of Finance | 14.4yrs | ₹56.90m | Veri yok | |
| Independent Non-Executive Director | 9.8yrs | ₹2.28m | Veri yok | |
| Independent Director | less than a year | Veri yok | Veri yok | |
| Independent Director | 2.8yrs | ₹1.82m | Veri yok | |
| Independent Director | 1.5yrs | ₹2.10m | Veri yok |
9.8yrs
Ortalama Görev Süresi
59yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: APLLTD 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 9.8 yıldır).